期刊文献+

骨桥蛋白在中枢神经系统白血病患者中的表达及意义 被引量:1

Expression of Osteopontin in Central Nervous System Leukemia and Its Clinical Significance
下载PDF
导出
摘要 本研究旨在探讨骨桥蛋白(OPN)在中枢神经系统白血病(CNSL)患者中的表达,了解其对CNSL的临床意义。采用ELISA法检测62例儿科患者血清中OPN的表达及19例CNSL患者完全缓解(CR)后OPN的表达,用RT-PCR检测CNSL患者骨髓中OPN的表达变化。结果表明,ELISA检测出OPN在CNSL、急性白血病(非髓外浸润)、非肿瘤患者中水平分别是25.21±6.87、13.24±2.73和3.14±1.60 ng/ml,差异具有显著性;在19例CNSL完全缓解后OPN水平是4.35±1.50 ng/ml,较治疗前明显降低(P<0.001);RT-PCR显示OPN在CNSL患者骨髓中表达较其他2组高(P<0.01)。结论:OPN在白血病中枢神经系统浸润中起着一定的作用,其机制有待临床进一步探讨。 This study was aimed to investigate the expression of osteopontin (OPN) in central nervous system leukemia (CNSL) and to understand its clinical significance. The expression level of OPN in serum of 62 pediatric patients (22 cases of CNSL, 20 cases of acute leukemia without extramedullary infiltration and 20 cases of nontumor patients) and 19 cases of CNSL with complete remission( CR) were assayed by ELISA; the expression changes of OPN mRNA in bone marrow of the CNSL patients were detected by RT-PCR. The results indicated that the serum OPN level was significantly higher in CNSL group ( 25.21 ±6.87 ng/ml) than that in acute leukemia group( 13.24±2.73 ng/mi) (P 〈 0.001 ) and nontumorous group (3.14 ± 1.60 ng/ml) (P 〈 0.001 ) ; the serum OPN level (4.35 ±1.50 ng/ml) in CNSL group with CR decreased obviously (P 〈 0. 001 ) after therapy; RT-PCR analysis showed that the expression of OPN mRNA was higher in CNSL group as compared with other two groups ( P 〈 0.01 ). It is concluded that the OPN expression may play a role in central nervous system infiltration of leukemia, the mechanism of which remains to need further clinical exploration.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第2期325-328,共4页 Journal of Experimental Hematology
基金 温州市科技局项目(编号Y20090425)
关键词 骨桥蛋白 白血病 中枢神经系统 osteopontin leukemia central nervous system
  • 相关文献

参考文献12

  • 1Pui CH. Central nervous system disease in acute lymphoblasticleukemia:prophylaxis and treatment. Hematology,2006 ; 2006(1):142-146.
  • 2顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:472
  • 3方建培,陈纯,金润铭.儿童白血病的诊断和治疔.北京:人民卫生出版社.2008.214.
  • 4Allan AL,George R,Vantyghem SA,et al. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breastcancer. Am J Pathol. 2006; 169(1) :233 -246.
  • 5Ito T,Hashimoto Y,Tanaka E,et al. An inducible short-hairpinRNA vector against osteopontin reduces metastatic potential ofhuman esophageal squamous cell carcinoma in vitro and in vivo.Clin Cancer Res,2006;12(4) :1308 - 1316.
  • 6El Touny LH,Baneijee PP. Identification of a biphasic role forgenistein in the regulation of prostate cancer growth and metastasis.Cancer Res,2009 ;69(8) :3695 -3703.
  • 7Lee JL,Wang MJ,Sudhir PR,et al. Osteopontin promotesintegrin activation through outside-in and inside-out mechanisms :OPN-CD44V interaction enhances survival in gastrointestinal cancercells. Cancer Res,2007;67(5) ;2089 -2097.
  • 8Liersch R,Gerss J,Schliemann C,et al. Osteopontin is aprognostic factor for survival of acute myeloid leukemia patients.Blood,2012;119(22) :5215 -5220.
  • 9Chagan-Yasutan H,Tsukasaki Takahashi Y ,et al. Involvementof osteopontin and its signaling molecule CD44 in clinicopatho-logical features of adult T cell leukemia. Leuk Res,2011 ;35( 11):1484-1490.
  • 10孙艳花,陈子兴,江森,岑建农,姚利.急性白血病患者脑脊液中可溶性CD44的测定及其在中枢神经系统白血病诊断中的意义[J].中华血液学杂志,2011,32(1):57-58. 被引量:5

二级参考文献16

  • 1Ristamaki R,Joensuu H,Gron-Virta K,et al.Origin and function of circulating CD44 in non-Hodgkin' s lymphoma.J Immunol,1997,158:3000-3008.
  • 2Naor D,Sionov RV,Ish-Shalom D.CD44:structure,function,and association with the malignant process.Adv Cancer Res,1997,71:241-319.
  • 3Kajita M,Itoh Y,Chiba T,et al.Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.J Cell Biol,2001,153:893-904.
  • 4Nagano O,Murakami D,Hartmann D,et al.Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca (2 +) influx and PKC activation.J Cell Biol,2004,165:893-902.
  • 5Murai T,Miyazaki Y,Nishinakamura H,et al.Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration.J Biol Chem,2004,279:4541-4550.
  • 6Nakamura H,Suenaga N,Taniwaki K,et al.Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.Cancer Res,2004,64:876-882.
  • 7Yu Q,Toole BP.A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.J Biol Chem,1996,271:20603-20607.
  • 8Franzmann EJ,Reategui EP,Pedroso F,et al.Soluble CD44 is a potential marker for the early detection of head and neck cancer.Cancer Epidemiol Biomarkers Prev,2007,16:1348-1355.
  • 9Guo YJ,Liu G,Wang X,et al.Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.Cancer Res,1994,54:422-426.
  • 10Kan M,Kanayama H,Naruo S,et al.Serological evaluation of soluble CD44 in renal cancer.Jpn J Cancer Res,1996,87:1191-1194.

共引文献479

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部